Joyce Tung, PhD, is Vice President of Research at 23andMe, and is responsible for 23andMe's human genetics research program of over ten million consented participants, including recruitment and data collection, new methods and tools development, genetic discovery for therapeutic target identification and validation, and academic and industry research collaborations. Since joining 23andMe in 2007, Joyce has been part of many of the company's key milestones - the launch of the consumer product, the first scientific publications and collaborations, the FDA authorization of genetic reports, and the launch of the therapeutics division. Before 23andMe, Joyce earned her Ph.D. in Genetics from the University of California, San Francisco where she was a National Science Foundation graduate research fellow, and was a postdoctoral fellow at Stanford University.